Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Loading live signals…
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Acquiring Company
CorMedix
Acquired Company
Melinta Therapeutics
Berkeley HeightsParsippanyBiotechnologyHealth CareTherapeuticsBiotechnologyTherapeuticsBiopharmaDescription
CorMedix has agreed to acquire Melinta Therapeutics, integrating seven approved therapies into its offerings. This acquisition enhances CorMedix's capabilities in hospital and acute care environments, focusing on branded anti-infective solutions. The deal represents a transition from a single product strategy to a diversified commercial platform.
Related People
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed